Home
This site is intended for healthcare professionals

Obstructive Sleep Apnea Care Pathways Translating Cardiometabolic Risk into Longitudinal Management: Module 5 Workflow-Integrated Screening

Share

Description

This activity is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals in the U.S.

Join Dr. Reena Mehra to discover actionable strategies for embedding OSA risk assessments into fast-paced, 15-minute primary care visits. This module explores how to leverage electronic health record (EHR) prompts and validated tools like the STOP-BANG questionnaire during routine check-ups to ensure high-risk patients are consistently identified and transitioned to diagnostic pathways without disrupting clinic workflows.

Session Highlights

  • Embed validated risk stratification tools, such as the STOP-BANG questionnaire, directly into patient intake processes or electronic health record (EHR) smart phrases to ensure consistent screening during rapid 15-minute visits.
  • Transition efficiently from a positive screening score to diagnostic activation, establishing clear workflows to order testing (HSAT or PSG) rather than treating an elevated score as a definitive diagnosis.

Prefer to watch in Spanish? Click Here

Who Should Participate?

This program is designed for healthcare professionals who seek to incorporate structured OSA screening and diagnostic activation into routine cardiometabolic management workflows.

  • Primary Care Physicians and Family Medicine Practitioners
  • Nurse Practitioners
  • Physician Assistants

This is Module Five of Six, See Modules 1, 2, 3, 4 and 6 Here.

Prefer to read? See our Key Clinical Summary Here.

Faculty

Dr Reena Mehra

Dr Reena Mehra, MD, MS is an Associate Professor of Medicine at Case Western Reserve University School of Medicine and a staff physician at the Cleveland Clinic, where she serves as the Director of Sleep Disorders Research within the Neurological Institute's Sleep Center. Her extensive research portfolio focuses on the intersection of sleep and cardiovascular health, specifically investigating the relationship between sleep-disordered breathing and abnormal cardiac electrophysiology. Through both epidemiological analyses and clinical trials, she explores how various sleep disorders contribute to cardiovascular disease, establishing her as a key contributor to the understanding of the hemodynamic and mechanistic links between sleep apnea and cardiac outcomes.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Dr Reena Mehra, Faculty for this activity has the following relevant financial relationships: Consultant, Advisory Board, Educational Media - Amgen, Apnimed, Centessa, Eli Lilly, Haymarket Media, and Mineralys.

The MedAll staff, program planners, and reviewers have no relevant financial relationships with ineligible companies to disclose.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associate Continuing Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 ANCC contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee for this educational activity.

This continuing education activity is active starting September 11th 2026, and will expire on July 1st 2028.

Learning objectives

1: Evaluate the bidirectional relationship between obesity and OSA to inform cardiometabolic risk assessment, demonstrating accurate identification of OSA risk within ≥75% of post-activity case-based assessments.

2: Identify patients at increased risk of OSA using clinical features and comorbidities in primary care, achieving appropriate risk stratification in ≥75% of applied clinical scenarios.

3: Apply workflow-compatible screening and triage strategies to support early identification of OSA, demonstrating correct use of structured tools and decision pathways in ≥75% of simulation-based exercises.

4: Select appropriate diagnostic and referral pathways, including HSAT, based on clinical presentation and practice context, achieving appropriate pathway activation in ≥75% of case-based assessments.

5: Apply longitudinal management and treatment progression strategies in OSA care planning to support sustained disease control, demonstrating appropriate decision-making in ≥70% of longitudinal case exercises.

6: Apply contextually adapted care strategies that account for socioeconomic and practice-setting factors to support equitable diagnostic and management decisions in OSA, demonstrating appropriate decision-making in ≥70% of applied scenarios.

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

My name is Rena Mira. I'm a professor of medicine and division head of pulmonary critical care and sleep medicine at the University of Washington. And it's a pleasure to be here with you today. We'll discuss workflow integrated screening for obstructive sleep apnea. So we will review firstly why screening fails in real life or what are the challenges that we face with screening for obstructive sleep apnea. So, in the reality of the primary care space, there are several constraints that occur. You know, the, in terms of the time that you have during the visit, The other, uh, competing, uh, aspects of health to address uncertain next steps, uh, not having the electronic health record support. So let's take these one by one. In terms of the constraints of the visit, um, oftentimes visits can be limited to 15 minutes. Uh, and because of that limitation in time, the screening for sleep apnea can therefore take a backseat and will drop below some of the other urgent issues that are at hand, uh, refills, chronic disease, uh, screening checks, and so forth. Uh, so, an area that can, um, help and improve this is embedding prompts into the patient intake to serve as reminders to ask about some of these symptoms of obstructive sleep apnea or characteristics. In terms of competing priorities, this is another challenge. Um, and sleep symptoms are At times can be dismissed in the relative scope of things or perhaps normalized or deferred, uh, because perhaps there are other issues that are Um, taking more precedence. So using a high-risk visit triggers. So if someone, for instance, says, you know, they have, um, episodes of stopping breathing during sleep or um their spouse notes them gasping during sleep, you know, these may be, for instance, triggers to really go down the path of looking into obstructive sleep apnea. Being uncertain of the next steps. So screening for sleep apnea um does not sometimes become testing or referrals. So, um, understanding kind of what the logical next steps are, once you have identified that the individual is at risk for sleep apnea and pairing that with them with the formal uh pathway in terms of diagnostics and management. And then in terms of not having the prompts embedded in the electronic health record, um, then it's relying on, uh, the memory of the clinician to sort of bring it up in the context of the entire visit, which sometimes does not happen. So using a smart phrase in the note, a checklist, or Some kind of flag in the system can really help to ensure that we're thinking about sleep apnea and capturing it. So, screening really succeeds when it is intentionally built into the visit workflow. The stop bang questionnaire is one of the screening questionnaires that's commonly used, and it is used commonly because it is, it is fairly straightforward and easy to use. So it allows for a bit of a fast risk stratification for obstructive sleep apnea. So we have stop bang, and each letter stands for a symptom or characteristic of the individual's snoring. Um, T is tiredness during the day. O, observed apnea. So this is really a specific symptom for obstructive sleep apnea. P represents pressure or history of hypertension. B for body mass index, uh, obesity, BMI of greater than 35 kg per meter squared. Age greater than 50 years of age and neck circumference of greater than 40 centimeters. There are different thresholds for men and women, uh, and G for gender, male sex gender. Uh, so, it used to be just the stop, but adding the bang has actually enhanced the sensitivity of this tool considerably for obstructive sleep apnea. So a score of 3 or more generally indicates increased risk for obstructive sleep apnea and therefore should Uh, lead to further evaluation for obstructive sleep apnea. And it's important to recognize that a positive screen does not equate a diagnosis of obstructive sleep apnea. So the screening tool really helps to identify those who have high pretest probability for obstructive sleep apnea and require further evaluation, um, not a diagnosis of obstructive sleep apnea in isolation in terms of just using the screening instrument. Therefore, the clinical judgment really remains very important, especially when there are atypical symptoms or comorbidities that may complicate the interpretation. So utilizing a structured pathway is recommended for diagnosing and treating of Obstructive sleep apnea. So if there's positive screening, as we just reviewed from the stop bang, then this prompts a clinical assessment. And in terms of diagnostics, uh, the tools that we have and the testing that we have available are the home sleep apnea tests or full polysomnography. And then you have a treatment plan which is developed accordingly um based upon the results of the sleep study. So let's review a case. Uh, so this is a patient case of, uh, screening, uh, without derailing the visit. So, Mr. R returns for a 15 minute diabetes follow-up. Uh, so there's medication review, a foot check, a refill request. These things are already on the agenda. Now, the case, uh, this, uh, The patient has been flagged, uh, due to obstructive sleep apnea risk as a stopping is completed prior to the clinician seeing the patient. And some of these, uh, elements of stopping can actually be, uh, in the medical record and can be pulled into the, uh, calculation of the stopping score. So, in this case, the score is increased based upon the patient's hypertension, uh, their body mass index, and symptoms of tiredness. So, again, 3 or more of these elements of stopping, uh, if they're positive, this is indicative of high pretest probability for obstructive sleep apnea. So, uh, in this case, the stopping was completed before the visit. So that really facilitates things in terms of understanding, uh, the risk for sleep apnea, and, uh, the clinician entry needs to be acknowledged and actioned appropriately in this busy clinic. Uh, so, briefly explaining, uh, the relevance to the patient of the stopping results, documenting the score, and then moving forward, uh, to facilitate the next step, which is a diagnostic study. So, the workflow has to carry the task, otherwise, it will be dropped when the visit runs long. And so, integrating it intentionally, uh, in this case, doing it before the patient comes in, having the information in hand, and then being able to, um, in a more expeditious way, uh, explain the results of the screen to the patient and then implement the next steps. So we have a polling question. What is your biggest barrier to using a screening tool consistently in practice? A lack of time. B, not built into workflow, workflow or electronic health record. C, uncertainty after a positive score. D, not a habit yet. So please uh complete the poll. In terms of the electronic health record, uh, there is a mechanism to have an EHR ready stop bang, uh, template. So a dot phrase, a smart phrase in the electronic health record can be Uh, of, uh, great, uh, help to facilitate the screening. So .OSA risk screen completed using stop bang, and it has the, uh, eight elements that are, uh, that comprise the, the stop bang instrument. Risk factors, so symptoms of, uh, snoring, observed apneas, hypertension, BMI, age, neck circumference, male sex, as we've reviewed, and then